Seeking Alpha

Rockford Coscia  

Rocky spent time with Pfizer Global Research and Development and with Esperion Therapeutics before attending Columbia University to pursue a Ph.D. in organic chemistry. At Pfizer, Rocky worked in the Chemical Research and Development department working on early scale-up of potential drug molecule syntheses. At Esperion, he synthesized small peptide therapies for the treatment of atherosclerosis.

Rocky went on to receive his Ph.D. in organic chemistry from Columbia University. His thesis topic involved the development of several novel synthetic methodologies. He is currently a consultant in New York City.

Selected publications:

“Development of a Formal [4+1] Cycloaddition: Pd(OAc)2-Catalyzed ...More
  • Description: Occasional Investor. Trading frequency: Weekly
  • Interests: Options, Stocks - long, Stocks - short
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no book details. Click edit to add book details.